Form 4: Comerica EVP Christine M. Moore Reports Stock Option Exercise and Sale

Sentiment:

SEC Form 4 Filing


Christine M. Moore, EVP and General Auditor of Comerica Incorporated, exercised stock options and sold shares on August 23, 2024.

Summary

  • On August 23, 2024, Christine M. Moore, EVP and General Auditor of Comerica Incorporated, exercised employee stock options to acquire 2,545 shares of common stock at a price of $42.32 per share.
  • Following the exercise, Moore sold 2,413 shares at $57.51 per share and 132 shares at $57.57 per share.
  • After these transactions, Moore directly owns 27,910 shares of Comerica common stock, inclusive of shares acquired through employee stock plans, reinvested dividends, restricted stock units, and deferred compensation plans.
  • Moore also holds options to purchase additional shares of Comerica common stock at various exercise prices and expiration dates.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by an executive, with no inherent positive or negative sentiment.

Positives

  • The exercise of stock options and subsequent sale suggests confidence in the company's prospects, as the executive is realizing gains from previously granted options.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are closely monitored by investors for insights into management's perspective on the company's value and future prospects.

Comparison to Industry Standards

  • Executive compensation practices, including stock options, are standard across the financial services industry.
  • Comparing Comerica's executive compensation structure and insider trading activity to peers like KeyCorp (KEY), Fifth Third Bancorp (FITB), and PNC Financial Services (PNC) can provide a benchmark for assessing whether these transactions are typical or indicative of unique circumstances.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely negligible.

Key Dates

DateDescription
01/27/2016Date of first vesting for one of the employee stock option grants.
01/26/2017Date of first vesting for one of the employee stock option grants.
01/24/2018Date of first vesting for one of the employee stock option grants.
01/23/2019Date of first vesting for one of the employee stock option grants.
01/22/2020Date of first vesting for one of the employee stock option grants.
01/28/2021Date of first vesting for one of the employee stock option grants.
01/26/2022Date of first vesting for one of the employee stock option grants.
01/25/2023Date of first vesting for one of the employee stock option grants.
01/24/2024Date of first vesting for one of the employee stock option grants.
01/23/2025Date of first vesting for one of the employee stock option grants.
08/23/2024Date of stock option exercise and sale of shares.
08/26/2024Date of Form 4 filing.
01/26/2026Expiration date for one of the employee stock option grants.
01/24/2027Expiration date for one of the employee stock option grants.
01/23/2028Expiration date for one of the employee stock option grants.
01/22/2029Expiration date for one of the employee stock option grants.
01/28/2030Expiration date for one of the employee stock option grants.
01/26/2031Expiration date for one of the employee stock option grants.
01/25/2032Expiration date for one of the employee stock option grants.
01/24/2033Expiration date for one of the employee stock option grants.
01/23/2034Expiration date for one of the employee stock option grants.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.